“…12,13 In a previous study on the anti-inflammatory constituents of traditional medicinal plants, we analyzed the water extract of D. asper roots, which showed significant half-maximal inhibitory activity (IC 50 = 45.1 µg/mL) against the production of nitric oxide (NO) in lipopolysaccharide (LPS)-activated murine macrophage RAW264.7 cells. Through bioassay-guided fractionation of the water extract, we isolated a new pyridine alkaloid-coupled iridoid glucoside (dipasperoside A), a new trisiridoid glucoside (dipasperoside B), and a known monoterpene indole alkaloid (3β,5α-tetrahydrodesoxycordifoline lactam), as well as 8 known iridoids (cantleyoside, dipsanosides A and B, loganic acid, loganin, sweroside, sylvestroside I, triplostoside A), 4 phenolics (3,4-dihydroxybenzaldehyde, 3,4-dihydroxybenzoic acid, caffeic acid, and vanillic acid), 3 known quinic acid derivatives (3,4- 14,15 Thereafter, we analyzed their NO production inhibitory activity against LPS-activated RAW264.7 cells and identified dipasperoside A (IC 50 = 15.2 µM) and akebia saponin D (IC 50 = 12.7 µM) as active constituents. 14 In the present study, as part of our ongoing phytochemical investigation of this plant, we isolated 2 monoterpenoid glucoindole alkaloids from the methanol (MeOH) extract of D. asper roots and identified therein a new alkaloid, (3R,5S)-5carboxyvincosidic acid 22-loganin ester (1), and the known alkaloid, (3S,5S)-5-carboxystrictosidic acid 22-loganin ester (dipsaperine 16 ) (2) (Figure 1).…”